Technology And Equipment Tenders

Open House Discount Agreements 2025-01

Medicines with the Active Ingredient Dimethyl Fumarate (Atc: L04ax07)

Open House Original Discount Agreements 2025-04 - Emtricitabine/Tenofovir Alafenamide/Rilpivirine (Odefsey(R))

Open House Original Discount Agreements 2025-01 - Bictegravir/Emtricitabine/Tenofovir Alafenamide (Biktarvy(R))

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Adalimumab (Atc Code According to Who: L04ab04)

Conclusion not Excluding Drug Discount Agreement. According to Section 130A Paragraph 8 Sgb V through an Open House Model for the Active Ingredient Etanercept (Atc Code According to Who: L04ab01)

Open House Drug Discount Agreements Botulinum Toxin Type A, Finished Drug Name Xeomin(R), Atc M03ax21

Open House Drug Discount Contracts Goserelin, Atc L02ae03

Open House Drug Discount Agreements Colecalciferol, Non Rx, only Products that can be Prescribed According to Appendix 1 Am-Rl G-Ba, Atc A11cc05

Conclusion of a Non-Exclusive Discount Agreement in Accordance with Section 130A Paragraph 8 Sgb V for the Active Ingredient Nebivolol, (Obg) Atc C07ab12 for the Period March 1St, 2025 - February 28Th, 2027